A special commitment to innovation
Through our deeply ingrained commitment to innovative R&D, Nexus Pharmaceuticals identifies those off-patent and unique molecules that can be developed, improved upon and commercialized so as to advance industry standards and deliver on the critical medical need.
We seek out difficult-to-formulate molecules with significant medical need
We innovate and improve the formulations to advance industry practice
We maintain the highest standards to deliver FDA-approved, life-saving drugs
A special attention to quality
Through our partnerships with leading US-based industry suppliers and manufacturers, privately owned Nexus Pharmaceuticals can ensure consistent, dependable access to the highest-quality products. Our steadfast record of delivery ensures that our critical-need drugs are always available when and where they’re needed most.
Dicyclomine HCL Injection, USP
Prochlorperazine Edisylate Injection, USP
Procainamide HCL Injection, USP
Isoproterenol HCL Injection, USP
News
Nexus Pharmaceuticals Announces Great Places to Work® Certification
Nexus Pharmaceuticals is pleased to announce its certification as a Great Place to Work. Ninety percent of Nexus employees say the company is a great place to work.
Nexus Pharmaceuticals Ranks #574 in Inc. 5000 Fastest-Growing Private Companies in America
Nexus Pharmaceuticals is pleased to announce the company has ranked #574 in Inc. 5000’s Fastest-Growing Private Companies in America in 2019.
At Nexus Pharmaceuticals, improving the lives of patients and the people who care for them are at the heart of what we do every day.
Yannick Vidinhouede, Supply Chain Analyst
Find out what we’re about
Discover more and let’s start a conversation
Lincolnshire, IL 60069 United States
P: (847) 996-3790